2016
DOI: 10.2196/medinform.4739
|View full text |Cite
|
Sign up to set email alerts
|

Integration of Provider, Pharmacy, and Patient-Reported Data to Improve Medication Adherence for Type 2 Diabetes: A Controlled Before-After Pilot Study

Abstract: BackgroundPatients with diabetes often have poor adherence to using medications as prescribed. The reasons why, however, are not well understood. Furthermore, most health care delivery processes do not routinely assess medication adherence or the factors that contribute to poor adherence.ObjectiveThe objective of the study was to assess the feasibility of an integrated informatics approach to aggregating and displaying clinically relevant data with the potential to identify issues that may interfere with appro… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
7
0

Year Published

2017
2017
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(7 citation statements)
references
References 24 publications
(25 reference statements)
0
7
0
Order By: Relevance
“…This approach was identical to that taken by Moore et al 17 to define metabolic syndrome using NHANES data, except that the current study relies on patients’ medication use rather than physicians’ prescription to enhance accuracy because some struggle with medication adherence. 18 The continuous metabolic risk z score was used to supplement the dichotomous metabolic syndrome variable, because it incorporates components of metabolic disease risk into 1 variable. 15 To derive this score, continuously distributed measures of waist circumference, triglycerides (mg/dL), blood pressure (mm Hg systolic + mm Hg diastolic/2), 2-hour fasting glucose (mm/dL), and inverted fasting HDL-C (mg/dL) were standardized by subtracting the sample mean from the individual mean, and then dividing by the SD of the sample mean.…”
Section: Methodsmentioning
confidence: 99%
“…This approach was identical to that taken by Moore et al 17 to define metabolic syndrome using NHANES data, except that the current study relies on patients’ medication use rather than physicians’ prescription to enhance accuracy because some struggle with medication adherence. 18 The continuous metabolic risk z score was used to supplement the dichotomous metabolic syndrome variable, because it incorporates components of metabolic disease risk into 1 variable. 15 To derive this score, continuously distributed measures of waist circumference, triglycerides (mg/dL), blood pressure (mm Hg systolic + mm Hg diastolic/2), 2-hour fasting glucose (mm/dL), and inverted fasting HDL-C (mg/dL) were standardized by subtracting the sample mean from the individual mean, and then dividing by the SD of the sample mean.…”
Section: Methodsmentioning
confidence: 99%
“…Achieving real-world practice change takes a long time and is often incomplete [35-37]. EHR-based clinical decision support has been shown to improve clinical process measures across multiple clinical domains [38-48].…”
Section: Discussionmentioning
confidence: 99%
“…Once our RHTN computable phenotype is validated, we can subsequently explore the effect of the different drug classification methods on the RHTN phenotype in future work. Other future work will include incorporating RxNorm Term Type (SCDF, SCD, SBD, etc), indicating retired RxCUIs, expanding to other disease states (diabetes, chronic kidney disease, heart failure, etc), and exploring the application to clinical decision support within the EHR [34,35].…”
Section: Xsl • Fomentioning
confidence: 99%